These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Plasmapheresis and immunoadsorption for treatment and prophylaxis of recurrent focal segmental glomerulosclerosis in adult recipients of deceased donor renal grafts. Kandus A; Ponikvar R; Buturović-Ponikvar J; Bren AF; Oblak M; Mlinšek G; Kmetec A; Arnol M Ther Apher Dial; 2013 Aug; 17(4):438-43. PubMed ID: 23931886 [TBL] [Abstract][Full Text] [Related]
7. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091 [TBL] [Abstract][Full Text] [Related]
8. A case of recurrent focal segmental glomerulosclerosis (FSGS) involving massive proteinuria (>50 g/day) immediately after renal transplantation. Okamoto M; Koshino K; Sakai K; Nobori S; Matsuyama M; Ushigome H; Okajima H; Masuzawa N; Yoshimura N Clin Transplant; 2011 Jul; 25 Suppl 23():53-8. PubMed ID: 21623916 [TBL] [Abstract][Full Text] [Related]
9. Focal segmental glomerular sclerosis recurrence with massive proteinuria and anuria immediately after kidney transplantation. Maruyama M; Kitamura H; Akutsu N; Otsuki K; Hasegawa M; Aoyama H; Matsumoto I; Saigo K; Asano T Nephrology (Carlton); 2015 Jul; 20 Suppl 2():93-5. PubMed ID: 26031597 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic plasma exchange in recurrent focal segmental glomerulosclerosis following transplantation. Shariatmadar S; Noto TA J Clin Apher; 2002; 17(2):78-83. PubMed ID: 12210710 [TBL] [Abstract][Full Text] [Related]
11. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports. Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416 [TBL] [Abstract][Full Text] [Related]
12. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. McCarthy ET; Sharma M; Savin VJ Clin J Am Soc Nephrol; 2010 Nov; 5(11):2115-21. PubMed ID: 20966123 [TBL] [Abstract][Full Text] [Related]
13. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Dall'Amico R; Ghiggeri G; Carraro M; Artero M; Ghio L; Zamorani E; Zennaro C; Basile G; Montini G; Rivabella L; Cardillo M; Scalamogna M; Ginevri F Am J Kidney Dis; 1999 Dec; 34(6):1048-55. PubMed ID: 10585314 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group. Trachtman H; Vento S; Herreshoff E; Radeva M; Gassman J; Stein DT; Savin VJ; Sharma M; Reiser J; Wei C; Somers M; Srivastava T; Gipson DS BMC Nephrol; 2015 Jul; 16():111. PubMed ID: 26198842 [TBL] [Abstract][Full Text] [Related]
15. Recurrence of focal segmental glomerulosclerosis after renal transplantation: a case report. Akash N Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):91-4. PubMed ID: 17237899 [TBL] [Abstract][Full Text] [Related]
16. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation. Tsagalis G; Psimenou E; Nakopoulou L; Laggouranis A Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013 [TBL] [Abstract][Full Text] [Related]